Key facts
- Innova Vascular’s last known valuation is $50.5M (Jun 2025).
- It has raised $24.0M across 4 recorded rounds; the latest was Early Stage VC ($10.0M) in May 2025.
- Notable investors include MedTech Innovator, SeedFolio, Black Diamond Ventures, GEO MedTech Ventures, Cardiovascular Systems.
- Innova Vascular has filed 4 Form Ds with the SEC, most recently Jul 2025 ($10.0M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Innova Vascular
Funding rounds
4 roundsAbout Innova Vascular
Operatorof minimally invasive thrombectomy devices intended to remove clots in patients with venous thromboembolism, including pulmonary embolism and deep vein thrombosis. The company offers an aspiration catheter system and a clot retrieval system cleared for commercial use, enabling hospitals and interventional specialists to perform catheter-based clot removal procedures.
- Sector
- Healthcare
- HQ
- Irvine, CA, United States
- Founded
- 2018
- Employees
- 9
- Website
- innovavascular.com/
- Ownership
- Privately Held (backing)
Innova Vascular doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innova Vascular shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innova Vascular in its N-PORT filings yet. We sweep new filings monthly.